Real-time enrollment status for this prevention of pneumonic plague resulting from aerosol exposure to yersinia pestis clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 2:29 PM UTC
| NCT Number | NCT07207408 |
| Recruiting Status | Recruiting |
| Condition | Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis |
| Phase | PHASE2 |
| Target Enrollment | 148 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Dynavax Technologies Corporation |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of August 29, 2026: Clinical trial NCT07207408 is currently recruiting participants. This phase2 study for prevention of pneumonic plague resulting from aerosol exposure to yersinia pestis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Dynavax Technologies Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07207408 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07207408 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.